RAMPAGE: The FDA aggressive activity

Emergency Trade Alert

To view this email as a web page, go here.

Aggressive “Desk Clearing” FDA approvals have already fueled some of the biggest gains of 2021… And the final 61 days of 2021 could be the biggest yet! New studies conducted by researchers from Harvard University and MIT have concluded: “The U.S. Food and Drug Administration is approving drugs faster than ever.” The report notes…   “Approval spikes occur at the end of each calendar month” and before the “end of the year in a kind of ‘desk-clearing’ activity.” Dozens of stocks could pop in the final 61 days of 2021 as the FDA clears their backlog of drug approvals. It all starts with one single ticker being announced in my Emergency Biotech Briefing… Everyone who attends will leave with the single stock ticker that I believe is expected to be in the best position to thrive from a looming FDA decision… Watch This Emergency Meeting   Disclaimer & Disclosures The information in this email is intended for informational purposes only and does not guarantee specific results as there is a high degree of risk involved with trading. Also, our traders are real traders and may have financial interests in the companies discussed. Please see our Terms and Conditions for more information. Manage Your Email Preferences Unsubscribe This email was sent by: WealthPress 7751 Belfort Parkway #120 Jacksonville, FL, 32556, US New Money Crew Update Profile

Share on Facebook

Share on Twitter

Share on Google+

Share on LinkedIn

Subscribe to receive free email updates: